Ketogenic Diet and Metabolic Health: The Evidence, the Risks of Going It Alone, and Why Physician Certification Matters

The ketogenic diet has one of the most extensive and compelling evidence bases of any dietary intervention in modern medicine. From epilepsy — where it has been used therapeutically since the 1920s — to type 2 diabetes reversal, insulin resistance, cognitive function, and cardiovascular risk reduction, the keto diet is not a fad. But it is a physiologically powerful intervention that affects medications, labs, hormones, and body chemistry in ways that benefit enormously from clinical oversight. Dr. Johnny Gomes is keto-certified — making him one of a small number of physicians qualified to supervise this protocol as a clinical therapeutic tool.

What “Therapeutic Ketosis” Actually Means

A standard Western diet derives approximately 55–65% of calories from carbohydrates, maintaining blood glucose as the primary fuel for most tissues. The ketogenic diet reduces carbohydrate intake to typically below 20–50 grams per day — approximately 5% of total calories — forcing the liver to produce ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone) from fat. These ketones become the primary fuel for the brain, heart, and skeletal muscle.

Why Ketones Matter Beyond Weight Loss

Beta-hydroxybutyrate (BHB) is not merely a fuel molecule — it is a signaling compound with profound effects on gene expression, inflammation, and cellular repair. BHB inhibits the NLRP3 inflammasome — one of the most important drivers of sterile inflammation in chronic disease. It activates the FOXO3 transcription factor involved in longevity and stress resistance. And it provides the brain with a fuel source that bypasses the insulin resistance that impairs neuronal glucose metabolism — which is why the ketogenic diet shows promise in Alzheimer’s disease and cognitive decline research.

The Evidence Base for Ketogenic Therapy

Type 2 Diabetes and Insulin Resistance

Multiple randomized controlled trials have demonstrated that a well-formulated ketogenic diet produces HbA1c reductions comparable to or exceeding most oral diabetes medications, reduces fasting insulin dramatically, and allows many patients to reduce or discontinue medications under physician supervision. The Virta Health trial demonstrated that 87% of type 2 diabetes patients on a well-formulated ketogenic diet reduced or eliminated insulin therapy within one year.

Cardiovascular Risk Markers

Despite concerns about saturated fat, the ketogenic diet consistently improves the most clinically relevant cardiovascular risk markers: dramatically reduces triglycerides (often by 50–70%), raises HDL cholesterol, shifts LDL particles from the small-dense (atherogenic) to the large-buoyant (less atherogenic) pattern, and reduces blood pressure in hypertensive patients. Advanced lipid fractionation — not standard LDL — is the appropriate way to monitor this.

Neurological Conditions

The ketogenic diet was developed specifically for drug-resistant epilepsy, where it remains evidence-based first-line therapy. Its application has expanded to traumatic brain injury recovery, Alzheimer’s disease and mild cognitive impairment, Parkinson’s disease, migraine, and mood disorders — all conditions where altered brain energy metabolism plays a central role.

Why Physician Supervision Is Essential

Medication Management

Patients on insulin, sulfonylureas, SGLT2 inhibitors, blood pressure medications, or diuretics require careful medication adjustment as they transition to ketogenic eating. The diet’s effects on blood pressure and blood sugar can produce dangerous hypoglycemia or hypotension within days if medications are not reduced proactively under physician guidance. Dr. Gomes coordinates medication management throughout the dietary transition.

The Keto Adaptation Phase

The first two to four weeks of ketogenic eating involve significant metabolic adaptation — a shift in enzyme activity, mitochondrial infrastructure, and hormonal signaling that produces temporary symptoms collectively called “keto flu”: fatigue, headache, brain fog, muscle cramps, and irritability. Understanding and managing this phase — primarily through electrolyte management and appropriate fat intake — requires clinical knowledge that most online keto resources don’t provide.

Individual Lab Response Monitoring

A minority of patients — particularly those with genetic variants affecting lipid metabolism, such as the APOE4 allele — show adverse lipid responses to high saturated fat intake on keto. Advanced lipid fractionation, not just standard cholesterol testing, is required to assess the true cardiovascular impact of the ketogenic diet in each individual patient. Dr. Gomes monitors this systematically.

Ketogenic Diet Patient Candidates

• Type 2 diabetes or prediabetes with insulin resistance
• Metabolic syndrome and significant central obesity
• Drug-resistant epilepsy (with coordinated neurological care)
• Cognitive decline or significant family history of Alzheimer’s disease
• Chronic migraine unresponsive to standard management
• PCOS with insulin resistance component
• Patients seeking significant, rapid metabolic improvement as a foundation for other interventions